Evidence map›Paper›PMID 21953015›Full record

ArticleHepatology (Baltimore, Md.)2011

Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials?

Kathleen E Corey, Naga Chalasani

Abstract readEditorialComment
In one paragraph

Article in Hepatology (Baltimore, Md.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Therapeutic pipeline in nonalcoholic steatohepatitis.Nature reviews. Gastroenterology & hepatology · 2021
    Review
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Kathleen E Corey
Naga Chalasani

Funding

Patient-Oriented Research of Liver DiseaseK24DK069290 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI CHALASANI, NAGA P · 2005 to 2014
$1.4M
NIDDK NIH HHS K24 DK069290
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fatty LiverFemaleHumansLosartanMaleMetforminNon-alcoholic Fatty Liver DiseaseRosiglitazoneThiazolidinedionesLosartanMetforminRosiglitazoneThiazolidinediones

Identifiers

PMID21953015
PMCPMC3644213

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.